CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Gedeon Richter against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 24, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol HydrateASTRAZENECAFeb 9, 2024
Toxicity Management For Anti-Tumor Activity Of CarsTHE CHILDRENS HOSPITAL OF PHILADELPHIASep 28, 2023
Antitumor T Cell Response EnhancerCHUGAI SEIYAKU KABUSHIKI KAISHAJul 25, 2023
Early Intervention Methods To Prevent Or Ameliorate ToxicitySEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RESEARCH INSTITUTESep 20, 2022
Ovulation DeterminationVIVOSENSMEDICALApr 28, 2022
Toxicity Management For Anti-Tumor Activity Of CarsTHE CHILDRENS HOSPITAL OF PHILADELPHIAOct 6, 2021
Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol HydrateASTRAZENECADec 11, 2020
Toxicity Management For Anti-Tumor Activity Of CarsTHE CHILDRENS HOSPITAL OF PHILADELPHIANov 25, 2020
Method Of Increasing Bone Toughness And Stiffness And Reducing FracturesELI LILLYApr 27, 2018

Top competitors of Gedeon Richter

List of top competitors of Gedeon Richter based on patent oppositions.